📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis. (2019)

First Author: Richardson M

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.18.0324

PubMed Identifier: 30871660

Publication URI: http://europepmc.org/abstract/MED/30871660

Type: Journal Article/Review

Volume: 23

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 3

ISSN: 1027-3719